scholarly journals Comparison of the acute metabolic effect of different infant formulas and human milk in healthy adults: a randomized trial

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Yasaman Shahkhalili ◽  
Cathriona Monnard ◽  
Dominik Grathwohl ◽  
Julien Sauser ◽  
Maurice Beaumont ◽  
...  
Keyword(s):  
Human Milk ◽  
G Protein ◽  
Infant Formula ◽  
Venous Blood ◽  
Insulin Response ◽  
Healthy Adults ◽  
Intact Protein ◽  
Infant Formulas ◽  
Clinical Trial Registration ◽  
Glucose Response

Abstract Background/Objectives Different infant formulas, varying in protein type and quantity, are available for infants who are not breastfed or are partially breastfed. Postprandial insulinemic and glycemic responses to intact vs partially hydrolyzed protein in infant formula are unclear. To compare the effect of different forms (partially hydrolyzed vs non-hydrolyzed) and levels of protein in infant formula compared with a human milk reference subgroup on insulin response in adults. Subjects/Methods In a randomized, double-blinded, cross-over study, 35 healthy adults consumed 600 ml of three different infant formulas: Intact protein-based formula (INTACT) (1.87 g protein/100 kcal; whey/casein ratio of 70/30; 63 kcal/100 ml), partially hydrolyzed whey-based formula (PHw) (1.96 g protein/100 kcal; 100% whey; 63 kcal/100 ml), a high-protein partially hydrolyzed whey-based formula (HPPHw) (2.79 g protein/100 kcal; 100%whey; 73 kcal/100 ml) and a subgroup also consumed human milk (HM) (n = 11). Lipid and carbohydrate (lactose) contents were similar (5.1–5.5 and 10.5–11.6 g/100 kcal, respectively). Venous blood samples were taken after overnight fasting and at different intervals for 180 min post-drink for insulin, glucose, blood lipids, GLP-1, glucagon, and C-peptide. Results Twenty-nine subjects (eight consuming HM) adhered to the protocol. INTACT and PHw groups had similar postprandial insulinemia and glycaemia (Cmax and iAUC) that were not different from those of the HM subgroup. HPPHw resulted in higher postprandial insulin responses (iAUC) relative to all other groups (p < 0.001, p < 0.001, p = 0.002 for the comparison with INTACT, PHw, HM, respectively). HPPHw resulted in a higher glucose response compared to INTACT and PHw (iAUC: p = 0.003, p = 0.001, respectively), but was not different from HM (p = 0.41). Conclusion This study in adults demonstrates similar postprandial insulinemia and glycaemia between INTACT and PHw, close to that of HM, but lower than HPPHw, which had a higher protein content compared to the other test milks. The findings remain to be confirmed in infants. Clinical trial registration This study is registered at clinicaltrials.gov, identifier NCT04332510.

scholarly journals Term infant formula supplemented with milk-derived oligosaccharides shifts the gut microbiota closer to that of human milk-fed infants and improves intestinal immune defense: A randomized controlled trial

2021 ◽  
Author(s):  
Elvira Estorninos ◽  
Rachel B Lawenko ◽  
Eisel Palestroque ◽  
Norbert Sprenger ◽  
Jalil Benyacoub ◽  
...  
Keyword(s):  
Immune Response ◽  
Randomized Controlled Trial ◽  
Gut Microbiota ◽  
Human Milk ◽  
Infant Formula ◽  
Controlled Trial ◽  
Immune Defense ◽  
Intact Protein ◽  
Phylogenetic Distance ◽  
Randomized Controlled

Abstract Background Bovine milk-derived oligosaccharides (MOS) containing primarily galacto-oligosaccharides with inherent levels of sialylated oligosaccharides can be added to infant formula to enhance the oligosaccharide profile. Objective To investigate the effects of a MOS-supplemented infant formula on gut microbiota and intestinal immunity. Methods In a double-blind, randomized, controlled trial, healthy-term formula-fed infants aged 21–26 days either received an intact protein cow's milk-based formula (control group, CG, n = 112) or the same formula containing 7.2 g MOS/L (experimental group, EG, n = 114) until age 6 months. Exclusively human milk-fed infants (HFI, n = 70) from an observational study served as reference. Fecal samples collected at baseline, 2.5 and 4 months of age were assessed for microbiota (16S ribosomal ribonucleic acid—based approaches), metabolites and biomarkers of gut health and immune response. Results At age 2.5 and 4 months, redundancy analysis (P = 0.002) and average phylogenetic distance (P &lt; 0.05) showed that the overall microbiota composition in EG was different from CG and closer to that of HFI. Similarly, EG caesarean-born infants were different from CG caesarean- or vaginally-born infants and approaching HFI vaginally-born infants. Relative bifidobacteria abundance was higher in EG vs. CG (P &lt; 0.05) approaching HFI. At age 4 months, counts of Clostridioides difficile and Clostridium perfringens were ∼90% (P &lt; 0.001) and ∼65% (P &lt; 0.01) lower in EG vs. CG, respectively. Mean (95%CI) fecal secretory immunoglobulin A (IgA) in EG was twice that of CG [70 (57,85) vs. 34 (28,42) mg/g, P &lt; 0.001] and closer to HFI. Fecal oral polio vaccine-specific IgA was ∼50% higher in EG vs. CG (P = 0.065). Compared to CG, EG and HFI had lower fecal calcium excretion (by ∼30%) and fecal pH (P &lt; 0.001), and higher lactate concentration (P &lt; 0.001). Conclusions Infant formula with MOS shifts the gut microbiota and metabolic signature closer to that of HFI, has a strong bifidogenic effect, reduces fecal pathogens, and improves intestinal immune response.

scholarly journals Randomized Controlled Crossover Dose-Response Trial Shows Low Dose (2 g) Barley β-Glucan Provided in Waffles Lowers Post-Prandial Glycaemic Response In Healthy Adults

2020 ◽  
Vol 4 (Supplement_2) ◽  
pp. 615-615
Author(s):  
Heather Blewett ◽  
Nancy Ames ◽  
Jay Petkau ◽  
Sijo Joseph ◽  
Sora Ludwig
Keyword(s):  
Low Dose ◽  
Insulin Response ◽  
Healthy Adults ◽  
Least Square ◽  
Analysis Of Covariance ◽  
Glucose Response ◽  
Soluble Fibre ◽  
Randomized Controlled ◽  
Funding Sources ◽  
Visit Number

Abstract Objectives Barley β-glucan (BG) has reported post-prandial (PP) glycemic response lowering effects.  The objective of this study was to ascertain the minimum and most effective dose of BG on PP glucose and insulin response using waffles as the test food. Methods Healthy adults (7 men/17 women) completed a randomized controlled crossover trial at the Asper Research Institute in Winnipeg, MB. Each participant attended five 2.5-hour study visits separated by 3–14 days (average = 7 days). At each visit participants ate waffles containing 30 g available carbohydrates (AC) with varied doses of BG (0, 2, 4, or 6 g). Wheat waffles with low fibre and protein (0g-1) and wheat waffles matched to BG waffles for insoluble dietary fibre and protein (0g-2) were used as controls. The order of treatments was random. Fasting, 15, 30, 45, 60, 90 and 120 minute PP capillary blood samples were collected for analysis of blood glucose and plasma insulin levels. Data were analyzed using analysis of covariance with treatment, participant, visit number and interaction between treatment and visit number included in the model. Differences (P ≤ 0.05) among treatments were determined using least square means adjusted using the Tukey option. Results There was a significant effect of treatment on both glucose and insulin iAUC (P &lt; 0.0001).  Glucose iAUC was 31–40% lower after eating 2, 4 and 6 g BG waffles compared to both 0 g waffles. Glucose iAUC was not significantly different between 0 g waffles or among BG waffles. Insulin iAUC was not significantly different between 0 g waffles. Insulin iAUC was 32% lower after eating 2 g BG compared to 0g-1, but not significantly different from 0g-2 waffles. Insulin iAUC was 36–58% lower after eating 4 and 6 g BG compared to both 0 g waffles, and 38% lower after eating 6 g BG compared to 2 g BG waffles. Conclusions The low dose (2 g BG per 30 g AC) provided a physiological benefit (reduction in PP glucose response &gt;20%).  Increasing dose to 4 or 6 g BG did not provide additional glucose lowering benefits, but insulin response decreased as BG dose increased.  Lack of difference in glucose and insulin iAUC between the two 0 g control waffles (insoluble fibre 1 g vs 8 g; soluble fibre 0 g), but higher PP glycemic responses than BG waffles emphasizes that the type of fibre is key to PP glycemic responses. Funding Sources Agriculture and Agri-Food Canada.

Differences in Vitamin E and C Profile Between Infant Formula and Human Milk and Relative Susceptibility to Lipid Oxidation

2013 ◽  
Vol 83 (5) ◽  
pp. 311-319 ◽  
Author(s):  
Ingrid Elisia ◽  
David D. Kitts
Keyword(s):  
Lipid Peroxidation ◽  
Vitamin E ◽  
Vitamin C ◽  
Human Milk ◽  
Lipid Oxidation ◽  
Infant Formula ◽  
Milk Formula ◽  
Infant Formulas ◽  
Vitamin E And C ◽  
Vit C

The vitamin E isoforms and vitamin (vit) C content of infant formulas were compared to human milk and related to relative susceptibilities to lipid peroxidation. We report that a highly distinct vitamin E and C profile exists between formula and human milk. Whileα-tocopherol (α-Toc) is the dominant vit E isoform in human milk, formula contains a substantial amount of α-Toc and δ-Toc that was greater than the level found in human milk (12- and 32-fold, respectively). Vitamin C was also two- fold higher in infant formula compared to human milk. Despite the higher vitamin E and C content, we also observed higher rates of lipid oxidation in the formula when compared to human milk. Storing human milk for one day at refrigeration temperatures did not produce hexanal in human milk, but this storage resulted in an increase in hexanal in formulas. We conclude that the higher concentrations of γ-Toc and δ-Toc in infant formulas did not provide similar protection from lipid oxidation as human milk. We also observed that vit C content was reduced during storage in both infant formula and human milk, which did not occur with the Toc isoforms.

scholarly journals A Validated Method for Detection and Quantitation of 2’Fucosyllactose in Infant Formula Matrices

2019 ◽  
Vol 7 (1) ◽  
Author(s):  
Pedro A. Prieto ◽  
Michael B. Miklus ◽  
Cynthia M. Barber ◽  
Steven M. Tennyson
Keyword(s):  
Human Milk ◽  
Infant Formula ◽  
Limit Of Detection ◽  
Soluble Carbohydrates ◽  
Infant Formulas ◽  
Chromatography Method ◽  
Elution Time ◽  
Potential Health ◽  
Main Challenge ◽  
Limit Of Quantitation

Analytical methods to assess the content of free carbohydrates in solution range from simple tests of reductive power to combinations of chromatography and mass spectrometry. Soluble carbohydrates such as lactose, maltose, fructooligosaccharides, and galactooligosaccharides are commonly found in infant formulas either as sources of energy or soluble fibers. On the other hand, a rich repertoire of lactose-based carbohydrates occurs naturally in human milk.  The advent of novel biosynthesis technologies resulted in the availability of human milk oligosaccharide structures that are being used as ingredients in infant formulas.   Notably, 2’Fucosyllactose has been tested in preclinical and clinical studies to determine its safety and to explore its potential health benefits in the context of pediatric nutrition. Several chromatographic methods for the analysis of human milk oligosaccharides have been published and, the main challenge associated with 2’Fucosyllactose quantitation has been to improve its resolution from lactose, which is present at concentrations around 70 g/l in both, infant formula and human milk. We developed a high-performance anion exchange chromatography method to detect and quantify 2’ Fucosyllactose in the presence of lactose by expanding the elution time between these saccharides. We validated the analytical procedure which behaved linearly (average R=0.99951) at concentrations as low as 1.75 µg/ml (limit of quantitation) with an average limit of detection of 0.43 µg/ml.

scholarly journals Use of Amino Acid Profiles of Pretermand Term Human Milks in Evaluating Scoring Patterns for Routine Protein Quality Assessment of Infant Formulas

1996 ◽  
Vol 79 (2) ◽  
pp. 498-502 ◽  
Author(s):  
Ghulam Sarwar ◽  
Pauline Darling ◽  
Mariko Ujiie ◽  
Herbert G Botting ◽  
Paul B Pencharz
Keyword(s):  
Amino Acids ◽  
Amino Acid ◽  
Human Milk ◽  
G Protein ◽  
Protein Quality ◽  
World Health ◽  
Complete Analysis ◽  
Infant Formulas ◽  
Health Organization

Abstract Reports on the amino acid composition of human milk vary considerably with respect to concentrations of sulfur amino acids. Often, analyses forego tryptophan determination. A complete analysis of protein and amino acid concentrations was performed on human milk samples (5-10 days postpartum) collected from mothers of preterm (gestations of 25-32 weeks) and term (gestations of &gt;36 weeks) infants. Careful attention was given to quantitate amino acids such as cysteine and tryptophan, which are vulnerable to acidic hydrolysis conditions. Differences in concentrations of total amino acids (expressed on protein basis) between preterm and term milks were small, despite the higher true protein content of preterm milk versus term milk (19.20 versus 12.60 g/L). The methionine + cyst(e)ine contents of term and preterm milks (3.72-3.84 g/100 g protein) were comparable with those reported in 1991 by the Food and Agricultural Organization/World Health Organization (FAO/WHO) for mature human milk (4.20 g/100 g protein) but higher than those reported in 1991 by the European Commission (2.9 g/100 g protein).The amino acid pattern of human milk obtained in this study confirms that the 1991 FAO/WHO amino acid scoring pattern for predicting protein quality of infant formulas is representative of the amino acid quality of both preterm and term human milks.

scholarly journals Comparison of the Bifidogenic Effects of Goat and Cow Milk-Based Infant Formulas to Human Breast Milk in an in vitro Gut Model for 3-Month-Old Infants

2020 ◽  
Vol 7 ◽  
Author(s):  
Sophie Gallier ◽  
Pieter Van den Abbeele ◽  
Colin Prosser
Keyword(s):  
Human Milk ◽  
Infant Formula ◽  
Goat Milk ◽  
Cow Milk ◽  
Common Source ◽  
Human Breast Milk ◽  
Infant Formulas ◽  
Infant Gut Microbiome

Human milk contains prebiotic components, such as human milk oligosaccharides (HMOs), which stimulate the growth of specific members of the infant gut microbiota (e.g., Bifidobacteria). Plant-based or synthetic oligosaccharides are often added to infant formulas to simulate the bifidogenic effect of HMOs. Cow milk, the most common source of protein in infant formula, and goat milk, used increasingly in the manufacture of infant formula, contain naturally-occurring prebiotics. This study compared the upper gastrointestinal digestion and subsequent colonic fermentation of human milk vs. goat and cow milk-based infant formulas (goat IF and cow IF, respectively), without additional oligosaccharides using an in vitro model for 3-month-old infants based on the Simulator of the Human Intestinal Microbial Ecosystem (SHIME®). First, a dialysis approach using 3.5 kDa membranes was demonstrated to simulate small intestinal absorption of carbohydrates in conditions similar to those in vivo. During the in vitro digestion experiment, oligosaccharides were detected in human milk and goat IF but barely detected in the cow IF. Further, all three milk matrices decreased colonic pH by boosting acetate, lactate, and propionate production, which related to increased abundances of acetate/lactate-producing Bifidobacteriaceae for human milk (+25.7%) and especially goat IF (33.8%) and cow IF (37.7%). Only cow IF stimulated butyrate production which correlated with an increase in Lachnospiraceae and Clostridiaceae. Finally, Enterobacteriaceae and Acidaminococcaceae also increased with all three milk matrices, while production of proteolytic metabolites (branched-chain fatty acids) was only detected for the cow IF. Overall, goat and cow milk-based formulas without added oligosaccharides impacted gut microbial activity and composition similarly to human milk. This suggests that even without supplementation of formula with oligosaccharides, whole goat milk, whole cow milk and cow milk ingredients already supply compounds in formulas that exert beneficial bifidogenic effects. Further clinical research is warranted to elucidate the effect of whole goat milk-based formulas on the infant gut microbiome.

scholarly journals What we should know about the carbohydrate component of infant formula

2021 ◽  
pp. 57-65
Author(s):  
I. N. Zakharova ◽  
A. A. Davydovskaya
Keyword(s):  
Infant Formula ◽  
Child Nutrition ◽  
Milk Proteins ◽  
Intact Protein ◽  
Infant Formulas ◽  
Carbohydrate Component ◽  
Lactase Deficiency ◽  
Glucose Syrup ◽  
Bowel Diseases

The article is devoted to the discussion of the carbohydrate component of infant formula for feeding healthy and sick children. The role of glycemic and non-glycemic carbohydrates is shown. In addition to lactose, the following glycemic carbohydrates can be used in infant formulas: maltose, sucrose, glucose, glucose syrup, maltodextrins, pretreated starch and gelatinized starch. Resistant oligosaccharides, nonstarch polysaccharides, and resistant modified starches are also used in child nutrition. The composition and amount of lactose, the main carbohydrate of women’s milk, is discussed. The article presents data on the role of galactose, which is conditionally essential for children in the first months of life due to the rapid growth rate of the infant. Information is presented on the lactose breakdown, the importance of enzymes in the digestion and assimilation processes, the prebiotic effects of lactose, and its effect on the absorption of calcium and other minerals. Advantages of lactose include its low glycemic index, as well as its reduced sweetness, which affects the proper development of taste and low risk of dental caries compared to other fermentable sugars. Specific requirements for the carbohydrate composition of low-lactose and lactose-free formulas are discussed because of the often unwarranted increase in the frequency of their use. Evidence is presented using the Cochrane Systematic Review (2018) that reducing or eliminating lactose from infant formulas in infants with infantile colic is not always appropriate. Special low-lactose and lactose-free formulas replace lactose with glucose polymers such as maltodextrin, glucose syrup, and solid glucose syrup, which are produced by hydrolyzing starches (corn, rice, or potato). The article discusses the data on the effect of maltodextrin on the state of the intestinal mucosa, the microbiota of the large intestine and the possible role of this ingredient in the pathogenesis of chronic inflammatory bowel diseases. The results of various studies regarding the effect of maltodextrin on the intestinal microbiota are contradictory. However, special low-lactose or lactose-free products are prescribed in the presence of symptoms of lactase deficiency in an artificially fed baby. It is a major mistake to prescribe lactose-free mixtures on the basis of intact protein or partially hydrolysed ones for secondary lactase deficiency caused by an allergy to cow’s milk proteins. The carbohydrate component of Friso therapeutic hydrolysates contains no maltodextrin, and lactose is partially or completely replaced with glucose syrup.

scholarly journals Bioactive Compounds in Infant Formula and Their Effects on Infant Nutrition and Health: A Systematic Literature Review

2021 ◽  
Vol 2021 ◽  
pp. 1-31
Author(s):  
Cristine Couto Almeida ◽  
Bianca Figueiredo Mendonça Pereira ◽  
Katia Christina Leandro ◽  
Marion Pereira Costa ◽  
Bernardete Ferraz Spisso ◽  
...  
Keyword(s):  
Literature Review ◽  
Human Milk ◽  
Infant Formula ◽  
Bioactive Compounds ◽  
Systematic Literature Review ◽  
Infant Nutrition ◽  
Infant Formulas ◽  
Nutrition And Health ◽  
Bioactive Ingredients ◽  
Formula Composition

Infant formulas are an alternative to replace or supplement human milk when breastfeeding is not possible. The knowledge of human milk’s bioactive compounds and their beneficial effects has attracted the interest of researchers in the field of infant nutrition, as well as researchers of technology and food sciences that seek to improve the nutritional characteristics of infant formulas. Several scientific studies evaluate the optimization of infant formula composition. The bioactive compound inclusion has been used to upgrade the quality and nutrition of infant formulas. In this context, the purpose of this systematic literature review is to assess the scientific evidence of bioactive compounds present in infant formulas (α-lactalbumin, lactoferrin, taurine, milk fat globule membrane, folates, polyamines, long-chain polyunsaturated fatty acids, prebiotics, and probiotics) and their effects on infant nutrition and health. Through previously determined criteria, studies published in the last fifteen years from five different databases were included to identify the advances in the optimization of infant formula composition. Over the last few years, there has been optimization of the infant formula composition, not only to increase the similarities in their content of macro and micronutrients but also to include novel bioactive ingredients with potential health benefits for infants. Although the infant food industry has advanced in the last years, there is no consensus on whether novel bioactive ingredients added to infant formulas have the same functional effects as the compounds found in human milk. Thus, further studies about the impact of bioactive compounds in infant nutrition are fundamental to infant health.

scholarly journals The Time Course of Human Milk Insulin and Glucose Response to an Oral Glucose Challenge - A Case Study (P11-045-19)

2019 ◽  
Vol 3 (Supplement_1) ◽  
Author(s):  
Bridget Young ◽  
Sarah Westmoreland ◽  
Carl D'Angio ◽  
Nancy Krebs
Keyword(s):  
Human Milk ◽  
Time Course ◽  
Serum Insulin ◽  
Insulin Response ◽  
Maternal Blood ◽  
Oral Glucose ◽  
Maternal Circulation ◽  
Glucose Response ◽  
Glucose Challenge ◽  
The Impact

Abstract Objectives It is often cited that insulin in human milk (HM) increases postprandially along with maternal serum insulin. However, this response has never been documented in humans, and the characteristics of this increase remain unstudied. Methods Two healthy lactating women emptied their breasts after a fast (> 8 hours) using an electric breast pump. After consuming a 50g glucose water, each woman emptied a single breast at 15, 30, 60, 90, and 120 minutes. Skim milk was generated via centrifugation and HM glucose and insulin were measured via hexokinase assay and chemiluminescent immunoassay (Beckman Coulter). At each of these time points maternal blood was collected via finger prick and capillary glucose measured via handheld glucometer. Additional blood was spotted onto a dried blood spot (DBS) card, and maternal insulin was measured from the DBS cards via Ultrasensitive ELISA (Mercodia). Results Both insulin and glucose concentrations rose in HM after the glucose load (Figure A, B). The amplitudes of both HM insulin and glucose were lower than that of maternal circulation. Neither HM insulin nor glucose were correlated with concentrations in maternal blood. However insulin concentrations were tightly correlated with glucose concentrations in both HM (P < 0.0001, R2 = 0.84) and maternal blood (P < 0.001, R2 = 0.72). At 2 hours post-glucose challenge, both maternal blood insulin and glucose had returned to near fasting levels (insulin: 15.1 ± 7.8 µU/mL; glucose: 107 ± 4 mg/dL). However, HM insulin and glucose concentrations remained elevated (Figure A, B). At 2 hours, HM insulin remained 13 times higher than fasting concentrations and HM glucose remained 3.9 times higher than fasting concentrations. Conclusions To our knowledge, these are the first data in humans to characterize the time course of HM insulin response to an oral glucose challenge. These data will inform the design of HM composition studies when free-living HM samples are collected. The impact of variation in these components over the day on the recipient infant deserves further research. Funding Sources Internally Funded. Supporting Tables, Images and/or Graphs

Sign in / Sign up

Export Citation Format

Share Document